Financial results - JENI PHARMA 2008 S.R.L.

Financial Summary - Jeni Pharma 2008 S.r.l.
Unique identification code: 24063391
Registration number: J15/823/2008
Nace: 4773
Sales - Ron
3.165
Net Profit - Ron
-2.715
Employees
1
Open Account
Company Jeni Pharma 2008 S.r.l. with Fiscal Code 24063391 recorded a turnover of 2024 of 3.165, with a net profit of -2.715 and having an average number of employees of 1. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Jeni Pharma 2008 S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 18.403 13.032 11.446 4.141 4.399 2.763 1.739 2.222 3.129 3.165
Total Income - EUR 18.425 13.032 11.446 4.141 4.399 2.763 1.739 2.222 3.129 3.165
Total Expenses - EUR 21.656 15.327 13.290 16.819 5.993 3.408 1.504 1.505 8.852 5.880
Gross Profit/Loss - EUR -3.231 -2.295 -1.843 -12.678 -1.594 -645 235 717 -5.723 -2.715
Net Profit/Loss - EUR -3.784 -2.639 -2.187 -12.803 -1.726 -728 183 650 -5.723 -2.715
Employees 1 1 1 1 1 1 0 0 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 1.7%, from 3.129 euro in the year 2023, to 3.165 euro in 2024.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Jeni Pharma 2008 S.r.l.

Rating financiar

Financial Rating -
JENI PHARMA 2008 S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Jeni Pharma 2008 S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Jeni Pharma 2008 S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Jeni Pharma 2008 S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Jeni Pharma 2008 S.r.l. - CUI 24063391

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets -19 0 0 0 0 0 0 0 0 0
Current Assets 13.192 13.546 13.743 6.849 10.818 12.763 4.659 6.108 2.394 3.173
Inventories 12.924 13.272 13.077 6.396 10.021 11.577 3.439 4.821 764 2.452
Receivables 2 2 2 331 519 742 953 991 959 913
Cash 266 272 664 122 277 445 267 296 671 -191
Shareholders Funds -20.345 -22.777 -24.578 -36.930 -37.940 -37.949 -47.032 -46.528 -52.110 -54.534
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 33.518 36.323 38.321 43.779 48.758 50.713 51.692 52.636 54.504 57.707
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 3.173 euro in 2024 which includes Inventories of 2.452 euro, Receivables of 913 euro and cash availability of -191 euro.
The company's Equity was valued at -54.534 euro, while total Liabilities amounted to 57.707 euro. Equity decreased by -2.715 euro, from -52.110 euro in 2023, to -54.534 in 2024.

Risk Reports Prices

Reviews - Jeni Pharma 2008 S.r.l.

Comments - Jeni Pharma 2008 S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.